The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Elı́as Campo(Hospital Clínic de Barcelona), Ari Melnick(Cornell University), Andrew D. Zelenetz(Memorial Sloan Kettering Cancer Center), Armando López‐Guillermo(Barcelona Supercomputing Center), Philippe Gaulard(Inserm), Jesús F. San Miguel(Clinica Universidad de Navarra), Steven H. Swerdlow(University of Pittsburgh), Irene M. Ghobrial(Dana-Farber Cancer Institute), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Jeffrey I. Cohen(National Institutes of Health), Shaji Kumar(Mayo Clinic), Eric D. Hsi(Mayo Clinic), María‐Victoria Mateos(Hospital Clínico San Carlos), Leticia Quintanilla‐Martínez(University Children's Hospital Tübingen), Falko Fend(Universitätsklinikum Tübingen), Kenneth C. Anderson(Dana-Farber Cancer Institute), John P. Leonard(New York University), Jonathan W. Friedberg(University of Rochester), Pierre Brousset(Université Toulouse III - Paul Sabatier), Stephen M. Ansell(Mayo Clinic), Ranjana H. Advani(Stanford Medicine), James R. Cook(Cleveland Clinic), John G. Gribben(Queen Mary University of London), Brad S. Kahl(UW Health University Hospital), Steven M. Horwitz(Memorial Sloan Kettering Cancer Center), Andrew Davies(University Hospital Southampton NHS Foundation Trust), Elizabeth Macintyre(Inserm), Laurence de Leval(University Hospital of Lausanne), Lorenzo Cerroni(Medical University of Graz), Julie M. Vose(University of Nebraska Medical Center), Steven P. Treon(Dana-Farber Cancer Institute), John F. Seymour(The Royal Melbourne Hospital), Camille Laurent(Institut universitaire du cancer de Toulouse Oncopole), Ann S. LaCasce(Otsuka (Japan)), Gilles Salles(Memorial Sloan Kettering Cancer Center), Paolo Ghia(Vita-Salute San Raffaele University), Elaine S. Jaffe(National Cancer Institute), Andrew L. Feldman(Mayo Clinic in Arizona), Stefan Dirnhofer(University of Basel), Wing C. Chan(City Of Hope National Medical Center), Emanuele Zucca(Università della Svizzera italiana), Carlos Barrionuevo(National University of San Marcos), Rebecca L. King(Mayo Clinic in Arizona), Won-Seog Kim(Samsung Medical Center), Georg Lenz(University Hospital Münster), Wing-Yan Au, Michael P. Link(Stanford University), Brunangelo Falini(University of Perugia), Leif Bergsagel(WinnMed), Francesco d’Amore(Aarhus University), John R. Goodlad(National Health Service)
Cited by 1,493
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
|New England Journal of Medicine|2014|3.5k